Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
企業コードSCNX
会社名Scienture Holdings Inc
上場日Feb 18, 2020
最高経営責任者「CEO」Dr. Narasimhan Mani
従業員数14
証券種類Ordinary Share
決算期末Feb 18
本社所在地- -
都市- -
証券取引所NASDAQ Capital Market Consolidated
国- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コードSCNX
上場日Feb 18, 2020
最高経営責任者「CEO」Dr. Narasimhan Mani
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし